Trials
Search / Trial NCT05651321

Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Dec 5, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

ClinConnect Summary

This clinical trial is studying how different people, including cancer and stroke patients, perceive taste when trying different oral nutritional supplements. The researchers want to understand how taste perception varies between healthy individuals and those with specific health conditions. Participants will taste various flavored nutritional drinks and provide feedback on their appearance, smell, and taste. This will help identify which flavors are most enjoyable for patients who may need these supplements to support their nutrition.

To participate, individuals must be between 18 and 80 years old, either healthy or diagnosed with certain conditions like cancer or stroke, and not currently undergoing treatment like chemotherapy. They should have good oral hygiene and be able to taste food normally. Participants will be asked to taste and evaluate several nutrition drinks, helping researchers learn more about what flavors work best for people in different health situations. It's important to note that those with allergies to the test foods, pregnant women, or individuals with certain medical conditions may not be eligible to join the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. healthy people aged 18-80 years old (including 18 and 80 years old), patients with specific diseases.
  • 2. specific diseases meet the clinical diagnosis criteria and are not in the clinical treatment period (such as radiotherapy or perioperative period)
  • 3. not wearing a denture and having good oral hygiene.
  • 4. normal vision or corrected vision, no hearing impairment, and no mental behavior disorder.
  • 5. voluntarily participate in this trial and sign the informed consent form.
  • Exclusion Criteria:
  • 1. subjects who may be allergic to the ingredients of the tested food
  • 2. persons who have an aversion to the food to be tasted or who do not consume the food for cultural, ethnic, or other reasons
  • 3. pregnant or lactating women.
  • 4. excessive smokers (\>15 cigarettes/day) or heavy drinkers (\>25g/day for men and \>15g/day for women)
  • 5. Eating disorders (binge eating, anorexia, bulimia nervosa, etc.) and those who cannot eat through the mouth
  • 6. those who underwent ear, nose, and throat, transnasal intracranial occupancy, and oral surgery
  • 7. Those who currently have severe abnormalities of the respiratory system, endocrine system, immune system, nervous system, circulatory system, digestive system, hematopoietic system, and nervous system, and those who have undergone bariatric surgery.
  • 8. currently taking medications that affect the sense of taste
  • 9. Subjects who are participating in other clinical trials.
  • 10. other people who have been determined by the investigator to be unsuitable for participation in this trial, patients with conditions that reduce the likelihood of enrollment or complicate enrollment, such as the presence of conditions that predispose to missed visits.

Trial Officials

Wei Chen, Doctor

Principal Investigator

Peking Union Medical College Hospital

About Peking Union Medical College Hospital

Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.

Locations

Beijing, Beijing, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials